Ameriprise’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-103,489
| Closed | -$209K | – | 3971 |
|
2023
Q4 | $209K | Sell |
103,489
-47,819
| -32% | -$96.6K | ﹤0.01% | 3716 |
|
2023
Q3 | $732K | Buy |
151,308
+329
| +0.2% | +$1.59K | ﹤0.01% | 3271 |
|
2023
Q2 | $1.03M | Buy |
150,979
+55,033
| +57% | +$376K | ﹤0.01% | 3159 |
|
2023
Q1 | $695K | Buy |
95,946
+37,171
| +63% | +$269K | ﹤0.01% | 3302 |
|
2022
Q4 | $754K | Buy |
+58,775
| New | +$754K | ﹤0.01% | 3254 |
|
2021
Q3 | – | Sell |
-3,796
| Closed | -$96K | – | 3975 |
|
2021
Q2 | $96K | Sell |
3,796
-1,410
| -27% | -$35.7K | ﹤0.01% | 3824 |
|
2021
Q1 | $101K | Sell |
5,206
-367
| -7% | -$7.12K | ﹤0.01% | 3770 |
|
2020
Q4 | $82K | Sell |
5,573
-7,568
| -58% | -$111K | ﹤0.01% | 3697 |
|
2020
Q3 | $296K | Buy |
+13,141
| New | +$296K | ﹤0.01% | 3425 |
|